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Summary: Morocco has made significant strides in building its HIV research capacity. Based on a wealth of empirical data, the
objective of this study was to conduct a comprehensive and systematic literature review and analytical synthesis of HIV
epidemiological evidence in this country. Data were retrieved using three major sources of literature and data. HIV transmission
dynamics were found to be focused in high-risk populations, with female sex workers (FSWs) and clients contributing the largest
share of new HIV infections. There is a pattern of emerging epidemics among some high-risk populations, and some epidemics,
particularly among FSWs, appear to be established and stable. The scale of the local HIV epidemics and populations affected show
highly heterogeneous geographical distribution. To optimize the national HIV response, surveillance and prevention efforts need to be
expanded among high-risk populations and in geographic settings where low intensity and possibly concentrated HIV epidemics are
emerging or are already endemic.
Keywords: Review, HIV, AIDS, epidemiology, Morocco, prevalence, sexually transmitted infection
INTRODUCTION
Morocco is an Arab and Muslim state situated at the
North-West corner of the African continent with a population
of over 32 million people.1 It is one of the few Middle East
and North Africa (MENA) countries that have made signiﬁcant
strides in building its HIV research capacity. With a relatively
interpretable volume of HIV epidemiological data, the objective
of this study was to conduct a comprehensive systematic
literature review and analytical synthesis of all available
HIV epidemiological evidence in this country. This is, to our
knowledge, the ﬁrst study to provide such an in-depth analysis
of the HIV epidemic in a speciﬁc country in the MENA region.
The overarching aim of our study is to provide the epidemiolo-
gical evidence necessary for the formulation of country-speciﬁc
HIV policies and programmes that are optimized to the context
of the epidemic in Morocco. The study also aims to inform
resource allocation of the HIV response at a time of ﬁnancial
challenges and competing priorities.
METHODS
We conducted a systematic literature review of HIV and related
data in Morocco. Studies and data were identiﬁed using three
sources:
(1) The MENA HIV/AIDS Epidemiology Synthesis Project.2,3
The Synthesis Project is a comprehensive gathering, compi-
lation, review and synthesis of all available biological,
behavioural and contextual data about HIV in MENA.
The project is the largest HIV epidemiology study in the
MENA region to date and is conducted through a joint part-
nership with the World Bank, the MENA Regional Support
Team (RST) of the Joint United Nations Programme on
HIV/AIDS (UNAIDS) and the Eastern Mediterranean
Regional Ofﬁce (EMRO) of the World Health Organization
(WHO). The study covers all countries in MENA including
Morocco. All studies relevant to HIV epidemiology in
Morocco identiﬁed through the Synthesis Project were
included in the present study. The methodology including
search strategies of the Synthesis Project are described in
previous publications,2,3 and are summarized in Section 1
of the Supplementary Information (SI) appendix.
(2) Systematic literature search in PubMed and Embase data-
bases. A detailed search focused speciﬁcally on published
HIV scientiﬁc literature in Morocco was conducted using
a strategy with both free text and MeSH/Emtree headings,
and with no language or year limitations. The following
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search criteria were used in PubMed: (‘HIV’[Mesh] OR
‘HIV Seropositivity’[Mesh] OR ‘HIV Antibodies’[Mesh]
OR ‘HIV Infections’[Mesh] OR ‘HIV Seroprevalence‘ [Mesh]
OR HIV [Text] or ‘Human immunodeﬁciency virus’[Text])
AND (‘Morocco’[Mesh] OR ‘Morocco’[Text]). The following
search criteria were used in Embase: (HIV.mp. or exp
Human immunodeﬁciency virus/) AND (Morocco.mp. or exp
Morocco/). This search was undertaken for further reassur-
ance that no studies on HIV in Morocco were missed
through the Synthesis Project search. The closing date for
this search was 6 October 2012.
(3) The Morocco HIV Modes of Transmission (MoT) Project.4,5
A number of studies and data sources were provided by the
Morocco Ministry of Health through the conduct of the
MoT study in Morocco. The additional literature and data
included country-level reports and unpublished data such
as summary measures on HIV case notiﬁcations.
RESULTS
Data sources
Most of the publications and data relevant to this study were
identiﬁed through the Synthesis Project. Out of all included
studies and/or data sources, 36 were exclusively identiﬁed
through the Synthesis Project, 31 were identiﬁed through the
PubMed and Embase searches, and 13 were identiﬁed
through the Morocco MoT Project.4,5 These contributions are
summarized in Supplementary Table S2.1. Of notice is that
these numbers refer to studies and/or sources of data, and any
one source of data may contribute more than one data point.
An example to this end is the US Census Bureau International
Database,6 which is counted as one source of data through
the Synthesis Project search, but contributed hundreds of data
points to this study.
HIV-infected population and HIV incidence
The number of people living with HIV (PLHIV) in Morocco in
2009 was estimated by the SPECTRUM model7 to be 26,000
with a range of 19,000–34,000.8,9 Supplementary Figure S2.1
depicts an increasing trend in the number of PLHIV starting
from 3400 in 1991 reaching up to 26,000 in 2009.9 The
SPECTRUM model also estimated a range of 1200–5800 new
HIV infections in 2009 (Supplementary Table S2.2).
Meanwhile, the MoT model10 estimated 3447 new HIV infec-
tions with a range of 2500–4400 in 2010.4,5
High-risk populations and HIV
Female sex workers and HIV
Table 1 and Figure 1 describe available HIV point-prevalence
measures among female sex workers (FSWs) and other high-
risk populations. Figure 1, which includes only national data
or data with a wide geographical coverage, suggests that HIV
prevalence among FSWs at the national level has hovered
around 2% and appeared rather stable for over a decade now.
This conclusion is supported by the fact that these data come
from different sources including both sentinel surveillance of
different types of FSWs, as well as a large volume of voluntary
HIV counselling and testing (VCT) data. This national-level
prevalence estimate, however, masks variability across the
regions. In the region of Sous Massa Draa for example, HIV
prevalence increased from 3.18% in 2005 to 8.14% in 2009
(Supplementary Table S2.3).15
In terms of the prevalence of female sex work, a study among
women hospital-attendees indicated that 0.5% of women
reported ever practicing sex work.17 As for available evidence
on sexual practices among FSWs, 70% of FSWs in one study
reported that they had more than four clients per week.14 The
average number of clients during the last seven days was 4.3
clients in another study, with 20.8% of them reporting one non-
paying sexual partner and 5.1% reporting multiple such part-
ners.18 Among those who were using different kinds of
drugs, 3.7% reported injecting drugs.18
As for condom use, 59.5% of FSWs reported consistent
condom use during vaginal sex in the last 30 days with their
clients, while during anal and oral sex, only 26.1% and 16.9%
of them had used condoms, respectively (Supplementary
Table S2.4).18 The main reason for non-condom use by 40% of
FSWs was reported to be objection of the client.18 Still, nearly
half of the sample reported refusal of sex in case no condom
was available.18 The levels of HIV/AIDS knowledge among
FSWs were fairly high (Supplementary Table S2.5).
Men who have sex with men and HIV
HIV prevalence among men who have sex with men (MSM)
ranged between 0% and 11% in different point-prevalence
measures (Table 1). Data on the prevalence of male to male
sex are limited. In a study among youth, 3.7% of men aged
15–24 reported ever having anal sex with a man.19 In a study
among a group of truck drivers, 8.7% reported having a
same-sex sexual partner during the last year.20
Injecting drug users and HIV
HIV prevalence among injecting drug users (IDUs) ranged
between 0% and 38% in different point-prevalence measures
and settings (Table 1). The prevalence of injecting drug use is
estimated at 0.1% with 18,500 IDUs in the country.21 In a
study conducted among a sample of drug users, the proportion
of IDUs among men was 75.3% and among women 66.2%.22 Of
the total IDUs in this study, 13.9% were women.22 Also, 59.9%
of all IDUs were unemployed.22 The study reported that 63.9%
of IDUs shared syringes; 76.9% of them would disinfect a
shared syringe before use with only 15.6% using proper
means to do so.22
IDUs appear to engage in high-risk sexual behaviour as
47.6% of men and 70.1% of women of this group of mainly
IDUs reported multiple sexual partners in the last 12
months.22 Moreover, 13.1% of men reported having same-sex
sexual relations, and 64.6% and 74.0% of men and women,
respectively, reported selling or paying for sex.22 Only 5.9%
of male IDUs and 19.5% of female IDUs reported consistent
condom use (Supplementary Table S2.4).22 IDUs tended to
have low levels of comprehensive HIV/AIDS knowledge
(Supplementary Table S2.5).
Potential bridging populations and HIV
Available data on HIV prevalence among potential bridging
populations, such as truck drivers, seamen and military person-
nel, suggest low HIV prevalence, generally well below 1%
................................................................................................................................................
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Table 1 HIV prevalence among different high-risk populations in Morocco as reported in different studies
Population Source Year
Sample
size
Prev.
HIV1
Prev.
HIV2 Comments
FSWs US Census Bureau6 1984–1987 27 3.7% Casablanca
US Census Bureau6 1989 28 7.14% Casablanca
US Census Bureau6 1989 28 0.00% Casablanca
US Census Bureau6 2001 217 2.30%
WHO/EMRO Database11 1.4%
Ministry of Health, 201012 2001 217 2.30% Sentinel surveillance, incarcerated
Ministry of Health, 201012 2002 350 3.14% Sentinel surveillance, incarcerated
US Census Bureau6 2003 264 2.27% Sentinel surveillance
Khattabi, 200513 2003 2.52% Sentinel surveillance, STI clinics
Ministry of Health, 201012 2003 148 2.03% Sentinel surveillance, incarcerated
Ministry of Health, 201012 2003 116 2.59% Sentinel surveillance, medical centres
Ministry of Health, 201012 2003 264 2.27% Sentinel surveillance, total FSWs
Ministry of Health, 201012 2004 332 0.90% Sentinel surveillance, incarcerated
Ministry of Health, 201012 2004 272 4.41% Sentinel surveillance, medical centres
Ministry of Health, 201012 2004 167 0.00% Sentinel surveillance, STI clinics
Ministry of Health, 201012 2004 771 1.95% Sentinel surveillance, total FSWs
Ministry of Health, 201012 2005 90 3.33% Sentinel surveillance, incarcerated
Ministry of Health, 201012 2005 125 1.60% Sentinel surveillance, medical centres
Ministry of Health, 201012 2005 215 2.33% Sentinel surveillance, total FSWs
Ministry of Health, 201012 2006 228 0.00% Sentinel surveillance, incarcerated
Ministry of Health, 201012 2006 303 0.33% Sentinel surveillance, medical centres
Ministry of Health, 201012 2006 119 0.00% Sentinel surveillance, STI clinics
Ministry of Health, 201012 2006 650 0.15% Sentinel surveillance, total FSWs
Ministry of Health, 201012 2007 178 3.37% Sentinel surveillance, incarcerated
Ministry of Health, 201012 2007 476 2.73% Sentinel surveillance, medical centres
Ministry of Health, 201012 2007 156 1.28% Sentinel surveillance, STI clinics
Ministry of Health, 201012 2007 810 2.59% Sentinel surveillance, total FSWs
Ministry of Health, 200814 2007 141 1.5% STD clinics, Agadir, Rabat, Sale´ & Tanger
Ministry of Health, 201012 2008 126 3.97% Sentinel surveillance, incarcerated
Ministry of Health, 201012 2008 712 1.83% Sentinel surveillance, medical centres
Ministry of Health, 201012 2008 241 2.07% Sentinel surveillance, STI clinics
Ministry of Health, 201012 2008 1,079 2.13% Sentinel surveillance, total FSWs
Ministry of Health, 201012 2009 151 3.97% Sentinel surveillance, incarcerated
Ministry of Health, 201012 2009 367 4.09% Sentinel surveillance, medical centres
Ministry of Health, 201012 2009 447 0.45% Sentinel surveillance, STI clinics
Ministry of Health, 201012 2009 965 2.38% Sentinel surveillance, total FSWs
Ministry of Health, 201012 2008 3461 1.2% VCT attendees
Ministry of Health, 201012 2009 5024 1.5% VCT attendees
MSM
US Census Bureau,6 1984–1987 52 3.85% Casablanca
WHO/EMRO Database11 1989 55 10.9%
Ministry of Health, 201012 2008 89 4.49% Sentinel surveillance
Ministry of Health, 201012 2008 1147 1.2% VCT attendees
Ministry of Health, 201012 2009 1216 2.2% VCT attendees
Ministry of Health, 201012 2009 39 0.00% Sentinel surveillance
IDUs Ministry of Health, 201015 2008 37.8% Nador
Ministry of Health, 201012 2005 133 0.0% Sentinel surveillance
Ministry of Health, 201012 2006 147 0.0% Sentinel surveillance
Mathers 2008,16 2006 6.5% Data from registration/case notification
Ministry of Health, 201012 2007 30 0.0% Sentinel surveillance
Ministry of Health, 201012 2008 61 1.6% Sentinel surveillance
Ministry of Health, 201012 2008 77 1.3% VCT attendees
Ministry of health, 201015 2008 0.0% RSA, Al-Hoceima
Ministry of Health, 201012 2009 16 6.3% VCT attendees
Ministry of Health, 201012 2009 66 0.0% Sentinel surveillance
NIDUs Ministry of Health, 201012 2008 95 0.0% Sentinel surveillance
Ministry of Health, 201012 2009 146 2.05% Sentinel surveillance
Suspected HIV
persons and
those reporting
risky behaviour
US Census Bureau6 1991–1998 5.5% National Center of Diagnosis
US Census Bureau6 1991–1999 12,981 5.05% National Center of Diagnosis
US Census Bureau6 1999 8.0% National Center of Diagnosis
FSWs ¼ female sex workers; MSM ¼men who have sex with men; IDUs ¼ injecting drug users; Prev ¼ prevalence; NIDUs ¼ non-injecting drug users; STIs ¼ sexually
transmitted infections; STD ¼ sexually transmitted disease; VCT ¼ voluntary HIV counselling and testing; RSA ¼ rapid situation assessment
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(Supplementary Table S2.6). Nevertheless, these populations
report relatively high levels of risk behaviour. Among truck
drivers in one study, 25% had more than 24 FSW partners
over the last year, 8.7% had same-sex sexual relations
(Supplementary Table S2.7) and 1.3% reported injecting drug
use.20 Only 29% of these truck drivers used a condom during
last sex (Supplementary Table S2.4).20 Though basic HIV
knowledge was high among these truck drivers, levels of mis-
information and negative attitudes towards PLHIV were also
high (Supplementary Table S2.5).
Prisoners and HIV
HIV prevalence among different prisoner samples ranged from
0% to 2% (Supplementary Table S2.8). Imprisonment in
Morocco is rather high at 174 per 100,000 persons.23,24
Prisoners reported higher levels of risk behaviour compared
with the general population, even prior to incarceration.
Female prisoners reported an average of 5.17 lifetime sexual
partners.25 Only 9% of them reported regular condom use
with all partners (Supplementary Table S2.4), and 2% reported
injecting drug use.25 In a study of mainly IDUs, 45.9% had a
history of incarceration for drug use and 19.8% injected drugs
while in prison.22
General population and HIV
HIV prevalence among the general population is very low and
there appears to be very limited HIV transmission within the
general population (Supplementary Table S2.9). Data on
sexual behaviour among this part of the population continue
to be rather limited. In one study among general population
women, almost 20% reported more than one lifetime sexual
partner, 2% reported more than three partners and 2% reported
having non-spousal sexual partners.17 The study reported a
mean lifetime sexual partners of 1.3, a median of 1, and a
range of 1–4. The median age at ﬁrst sex was 18 years.17
Polygamous unions were reported by 12% of the women,
and only 16% of them ever used condoms (Supplementary
Table S2.4).17 Though basic HIV/AIDS knowledge in the
general population is reported to be high, misinformation and
misconceptions were found abundant in different studies
(Supplementary Table S2.5).
Youth and HIV
Most of notiﬁed HIV infections in Morocco (63%) are among
young single persons,26 and 40% of recorded sexually trans-
mitted infection (STI) cases are also among youth aged 15–29
years.26,27 In a study among youth, 20.6% and 15.2% reported
ever having vaginal and anal sex, respectively.19 In the same
study, 67.2% of sexually active men reported ever having sex
with a FSW,19 and 43.1% of sexually active men and women
reported using no condom in the last month19
(Supplementary Table S2.4). The levels of comprehensive
HIV/AIDS knowledge varied among youth with both high
and low levels being reported as well as positive and negative
attitudes towards PLHIV (Supplementary Table S2.5). Female
adolescents appeared to have higher levels of knowledge than
male adolescents.28
Facility-based HIV surveillance
Facility-based HIV surveillance data indicate generally low HIV
prevalence among STI clinic attendees, VCT attendees and
tuberculosis patients among other facility-deﬁned populations
(Supplementary Table S2.10).
HIV/AIDS notified cases
During 1986–2009 a total of 4972 HIV/AIDS cases were noti-
ﬁed, of which 31.1% were asymptomatic HIV infections.15
More than half of HIV/AIDS cases (53.9%) were reported
during the period of 2005–2009 (Figure 2). The percentage of
women among notiﬁed HIV/AIDS cases increased steadily
from 19.3% in 1986–1989 to 47.9% in 2005–2009.15 In 2005–
2009, out of the total number of asymptomatic HIV cases,
61.6% were women.15 The 25–34 years and 35–44 years age
groups accounted for 38.4% and 32.1% of the total asympto-
matic HIV cases in 2005–2009, respectively.15
Figure 1 HIV prevalence among female sex workers in Morocco as reported in different studies,
2001–2009
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Multiple partnerships and an affected spouse were the main
risk factors accounting for 74% and 15% of HIV/AIDS notiﬁed
cases (all HIV infected, including AIDS patients) in 2005–2009,
respectively (Figure 2).15 In 2005–2009, Sous Massa Draa
accounted for about 25% of the total HIV/AIDS notiﬁed
cases, followed by Marrakech Tensift Al Haouz (21%) and
Grand Casablanca (12%) (Figure 2).15 Heterosexual trans-
mission continues as the predominant mode of transmission
among notiﬁed asymptomatic HIV cases (Figure 3),12 as well
as HIV/AIDS cases (Supplementary Table S2.11). The data
also suggest that the contribution of heterosexual transmission
among notiﬁed cases has been increasing in recent years.
Nevertheless, this increase may not strictly reﬂect a larger con-
tribution, as much as increased HIV diagnoses thanks to the
large expansion of VCTs targeting commercial sex networks
over the last few years. An additional factor, which may have
Figure 2 Analysis of notified HIV/AIDS cases by period, risk factor and geographic distribution in Morocco, 2005–200915
Figure 3 Distribution of notified asymptomatic HIV cases by modes of transmission, 1990–2009.12
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contributed to this apparent trend, is the improved quality of
HIV notiﬁcations. The percentage of notiﬁcations with an
‘unknown’ mode of exposure has diminished drastically over
the last few years.
Parenteral HIV transmission other than injecting
drug use
Available data suggest that HIV prevalence is low and
below 1% among populations at risk of HIV parenteral
acquisition (other than IDUs) such as haemodialysis patients,
haemophiliacs and poly-transfused patients (Supplementary
Table S2.12). However, occupational injuries among health-care
workers are common though rarely declared.29–31 Fifty-nine
percent of health-care workers in one study reported a needle
stick injury in the previous year.31 Hepatitis C virus (HCV) inci-
dence among haemodialysis patients was found to be very
high at 9.41 per 100 person-years.32 Supplementary Table
S2.13 shows considerable HCV prevalence among populations
at risk of HIV parenteral acquisition such as haemodialysis
patients, but very low HCV prevalence in the general
population.
Prevalence of STIs
Table 2 summarizes available prevalence measures of other
STIs in Morocco including human papillomavirus, herpes
simplex virus type 2 (HSV-2), syphilis, gonorrhoea and chlamy-
dia. STI prevalence levels are substantial in settings of high risk
such as among FSWs. Signiﬁcant levels of STI prevalence can
also be found in other population groups, though at much
lower prevalence.
HIV molecular epidemiology
HIV subtype B is the dominant HIV strain in Morocco and
accounted for 93.5% of infections in the 1990s.41 Nevertheless,
recent data suggest increasing diversity of strains with over
25% of the infections being of non-B subtypes, including
several circulating recombinant forms.42–45 A recent phyloge-
netic analysis showed that 39% of the recombinant strains
(CRF02_AG) were closely connected with reference strains
from Morocco, and 61% clustered with reference strains from
eight West African and three European countries.44
DISCUSSION
Based on the data reviewed and synthesized above, there is no
evidence for an HIV epidemic in the general population of
Morocco. However, similar to what is observed in other
MENA countries,2,3,46,47 a trend of rising epidemics among
high-risk populations seems to be emerging if not establishing
itself in Morocco, though at relatively low prevalence for the
last decade. HIV prevalence among potentially bridging popu-
lations appears to be limited. Although the risk of parenteral
HIV transmission (beyond injecting drugs) may be present at
low level in some speciﬁc population groups such as haemodia-
lysis patients, this mode of transmission appears to be very rare
in the general population as suggested by the low HCV preva-
lence in this population (Supplementary Table S2.13).
There is considerable evidence for HIV transmission among
FSWs and their clients in much of Morocco with a national
HIV prevalence among FSWs of about 2%. The HIV epidemic
among FSWs appears to be concentrated in the southern part
of the country, speciﬁcally in Agadir, where HIV prevalence
exceeds 5%, the threshold conventionally deﬁning a concen-
trated epidemic.48 There is also evidence for substantial levels
of STIs other than HIV among FSWs. FSWs appear to engage
in high-risk sexual behaviours at variable levels, but consistent
condom use appears also to be high with about half of coital
acts being protected by a condom. The HIV epidemic among
FSWs, though seemingly stable and with rather low prevalence,
is more intense than in most other MENA countries.2,3 The size
of commercial heterosexual-sex networks in Morocco appears
to be within the range found in other MENA countries, as
expressed by the prevalence of sex work among women,2,3
but it is somewhat towards the higher end of this range.
Commercial heterosexual-sex networks appear to be the
largest driver of HIV infection transmission in Morocco, as con-
ﬁrmed by the recent MoT analysis of new HIV infections.4,5
However, the size of the epidemic in these networks seems to
have been curtailed by the universal coverage of male circumci-
sion and the strong HIV response among FSWs. Multiple
non-governmental organizations (NGOs) with support and
collaboration with national authorities provide HIV-related ser-
vices to FSWs. There is a good coverage of VCT services among
FSWs particularly in the main cities, and it is estimated that
about 25% of VCT attendees in Morocco are FSWs.49 The
high level of condom use among FSWs, unlike any other popu-
lation group (Supplementary Table S2.4), testiﬁes to the success
of HIV response in commercial sex networks. In this regard,
Morocco is a pioneer and a leader in MENA in adapting its
HIV response to where needs are, and in implementing pro-
grammes among hidden high-risk and vulnerable populations.
Data on MSM continue to be limited in Morocco, though
studies are planned or ongoing to address this gap at least in
part. Available evidence suggests that HIV is circulating
among MSM, but that the size of the epidemic currently
seems to be rather moderate. Similarly, there is evidence for
HIV transmission among IDUs, but the contribution of this
mode of transmission to HIV case notiﬁcations appears to be
relatively small, and the fraction of the population injecting
drugs appears to be smaller than that in the eastern part of
MENA.2,3
The scattered data among MSM and IDUs suggest the
possibility of concentrated epidemics, but with a highly hetero-
geneous geographic distribution. The majority of HIV trans-
mission among MSM appears to be focused in the southern
part of Morocco, speciﬁcally in Agadir and Marrakech. HIV
transmission among IDUs appears to be focused in the north
of Morocco, particularly in Nador where a large HIV epidemic
has been identiﬁed recently.15 Nonetheless, we do not yet have
enough HIV surveillance data of good quality among MSM
and IDUs that can provide a representative picture of the HIV
epidemic in these populations. Localized hidden HIV epi-
demics among MSM and IDUs might be present in different
areas, but are yet to be identiﬁed and characterized. There is
also potential for further HIV epidemics among these popu-
lations in light of the risk-behaviour environment and the
context of emerging HIV epidemics among MSM and IDUs in
the MENA region.2,3,46,47
The analysis of notiﬁed HIV/AIDS cases indicates that mul-
tiple heterosexual-sex partnerships is the leading risk factor
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Table 2 Sexually transmitted infection (STI) prevalence among different population groups in Morocco, as reported in different
studies
STI Population Comment Source Prevalence
HPV General population Controls, hospital-based case-control study 17 21.0%
HSV-2 General population Men 11 10.0%
ANC attendees 33 12.7%
ANC attendees 34 12.9%
Women 11 13.0%
Family planning centre attendees 33 18.3%
Urban women with a median age of 40 years 35 26.0%
Facility based population STD clinic attendees 11 6.7%
Male HIV sentinel surveillance attendees 34 9.2%
Male HIV sentinel surveillance attendees 11 16.2%
Potential bridging population Military personnel 34 6.5%
Syphilis General population Male labourers 13 0.0%
Hotel staff 13 0.4%
Pregnant women 36 0.73%
Hotel staff 36 0.94%
Pregnant women 13 1.0%
Blood donors 37 1.3%
ANC attendees 33 1.6%
Seasonal female labourers 36 2.17%
11 2.8%
Seasonal female labourers 13 2.9%
Pregnant women 37 3.0%
Family planning centre attendees 38 3.4%
Family planning centre attendees 33 3.5%
Male labourers 36 4.51%
Symptomatic primary health-care centre attendees 38 5.6%
Facility-based population TB patients 13 2.3%
Females STD clinic attendees 14 2.40%
Females STD clinic attendees 11 2.70%
STD clinic attendees 13 3.80%
TB patients 36 4.0%
STD clinic attendees 11 4.0%
STD clinic attendees 36 4.92%
STD clinic attendees 39 13.2%
STD clinic attendees 38 18.4%
Vulnerable population Male prisoners 13 4.03%
Male prisoners 13 4.8%
Female prisoners 13 7.8%
Female prisoners imprisoned for sex work 13 9.6%
Female prisoners imprisoned for sex work 36 11.76%
Female prisoners 36 16.39%
Female prisoners 25 23%
Potential bridging population Sailors 13 1.9%
Sailors 36 3.37%
Truck drivers 13 9.55%
High-risk population FSWs 13 9.0%
FSWs 13 12.1%
FSWs 36 13.29%
FSWs 14 13.8%
FSWs 11 17.0%
Gonorrhoea General population ANC attendees 33 0.7%
Family planning centre attendees 33 1.0%
Family planning centre attendees 38 3.2%
Symptomatic primary health-care centre attendees 38 5.4%
Facility-based population Female STD clinic attendees 11 0.8%
Female STD clinic attendees 39 1.74%
Female STD clinic attendees 14 1.0%
Male STD clinic attendees 39 7.07%
STD clinic attendees 38 10.0%
STD clinic attendees 11 42%
STD clinic attendees 40 52.4%
High-risk population FSWs 11 3.5%
FSWs 14 7.1%
Chlamydia General population Family planning centre attendees 38 2.6%
ANC attendees 33 2.7%
Family planning centre attendees 33 5.2%
Symptomatic primary health-care centre attendees 38 6.3%
(Continued)
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for HIV acquisition, further conﬁrming the dominance of the
heterosexual mode of HIV transmission in Morocco. The
burden of HIV infection appears to be shifting from male dom-
inance to more or less equal distribution among men and
women. Thanks to VCT programmes expansion, the fraction
of asymptomatic HIV cases among all HIV/AIDS diagnosed
cases in 2005–2009 has increased compared with earlier years
(Figure 2). Nevertheless, case notiﬁcations still show that most
cases are being diagnosed at later stages suggesting an overall
low coverage of HIV testing among the populations most
affected by HIV. In Marrakech, 60.4% of newly diagnosed
HIV/AIDS cases were at an advanced stage of immunosuppres-
sion (,200 CD4þ cells/mm3), reﬂecting the delay in the diag-
nosis of HIV.50 Other STIs are also often diagnosed in advanced
stages. In one study of syphilis patients, 70.2% were identiﬁed
as late latent cases.51
In line with what is observed elsewhere in MENA,3 most of
the sexual risk behaviour appears to be practiced by men in
Morocco.4,5 Women are exposed to HIV through their infected
husbands or partners who are usually unaware of their infec-
tions.52 The acquisition of STIs was also found to be associated
with male rather than female sexual behaviour.38 The age-gap
in marriage appears to be yet another factor increasing the
risk of STIs among women in Morocco.17
The prevalence of STIs other than HIV in the population at
large (Table 2) is rather on the low side compared with global
levels, but is on the high side compared with other MENA
countries.3 For example, while the roughly 10% prevalence of
HSV-2 is lower than the levels found in other regions,53–55 it
is higher than what is found in other MENA countries.56
This pattern may relate to the relative size of commercial
heterosexual-sex networks in Morocco. While sexual behaviour
among the general population in Morocco is probably broadly
similar to that in other MENA countries,3 larger fraction of men
may be frequenting FSWs in Morocco compared with most
other MENA countries.
The dominant HIV strain in Morocco is subtype B reﬂecting
transmission pathways of West European origins and afﬁrming
the introduction of the virus to Morocco through the sizable
migration and tourism links between this country and West
Europe.41,45,46 However, recent data indicate increasing diver-
sity of HIV-1 variants reﬂecting sub-Saharan African immigra-
tion to Europe via Morocco or possibly acquisitions by
Moroccans traveling in sub-Saharan Africa.41–45 However, the
Africanization of subtypes, that is, the increased appearance
in Morocco of subtypes circulating in sub-Saharan Africa,
should not be interpreted as a major role for African migrants
in HIV transmission dynamics in Morocco. Though migration
contributed to the introduction of new HIV subtypes, the
totality of the epidemiological evidence synthesized here indi-
cates that the vast majority of HIV transmissions in this
country are linked to the domestic high-risk networks.
One limitation of the present study is that the quantity and
quality of data varied between different risk groups and geo-
graphic regions. There were not sufﬁcient data on MSM and
IDUs to characterize satisfactorily HIV transmission in these
populations. Most data were from cross-sectional surveys
using convenience sampling, and only recently representative
data from integrated bio-behavioural surveillance surveys
(IBBSS) became available. Sexual behaviour data were rather
limited, and conventional limitations of self-reported data
could have affected their quality. Though there is a substantial
improvement in the quality of HIV data with time, earlier
studies suffered from methodological limitations and/or were
mostly descriptive and qualitative in nature. Despite these
limitations, we have synthesized and corroborated ﬁndings
from different types of data sources such as HIV prevalence,
notiﬁed HIV/AIDS cases and sexual risk behaviour, among
other related and contextual data. Our search criteria were
expansive, and covered different sources of literature. Our inte-
grated data synthesis allowed us to address, at least in part,
potential limitations in any one line of evidence, and to draw
a comprehensive assessment of the HIV epidemic status in
Morocco.
CONCLUSION
The HIV epidemic in Morocco shares similarities with the HIV
epidemics found in the MENA region.2,3,46,47 HIV prevalence is
at very low levels in the general population and the dynamics
of HIV transmission are centred in the networks of high-risk
populations. HIV epidemics appear to be emerging among
high-risk populations, and some, particularly among FSWs,
appear to be established and rather stable.
Morocco has probably the most developed HIV surveillance
system, research capacity and response in the Arab World. Yet,
the current surveillance systems are focused on sentinel surveil-
lance, mainly covering general population groups and FSWs, in
addition to passive reporting of HIV/AIDS notiﬁed cases. Only
recently, sentinel surveillance has been extended to include
MSM and IDUs, but still with limited geographic coverage. A
critical need in terms of HIV surveillance is the conduct of
IBBSS surveys among high-risk populations across the
country. This has been initiated recently among IDUs in north
of Morocco, and among MSM in Southern Morocco. While
this is an important progress, IBBSS surveillance should be
extended to all high-risk populations with wide geographic
coverage. There is a possibility that hidden HIV epidemics
Table 2 Continued
STI Population Comment Source Prevalence
Facility based population
STD clinic attendees 38 5.0%
Female STD clinic attendees 14 5.6%
STD clinic attendees 11 6.0%
STD clinic attendees 40 17.1%
STD clinic attendees 39 51.5%
High-risk population FSWs 14 19.1%
ANC ¼ antenatal clinic; FSWs ¼ female sex workers; HPV ¼ human papillomavirus; TB ¼ tuberculosis; HSV-2 ¼ herpes simplex virus type 2; STD ¼ sexually transmitted
disease; STI ¼ sexually transmitted infection
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among IDUs and MSM exist, but have not yet been captured by
the current surveillance infrastructure.
To optimize HIV control and to prioritize prevention inter-
ventions at a time of competing priorities, HIV programmes
should focus on access to counselling, testing, care and treat-
ment services among high-risk populations and in geographic
settings where low intensity or concentrated epidemics are
emerging or are already established. Morocco has made admir-
able strides in tackling the HIV public-health challenge and in
establishing HIV programmes. The new challenges for HIV
policy in this country is a refocus of efforts towards where
most-pressing needs are.
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